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In a continuation of our chemical and biological investigations on Zingiberaceae 
species, we have now studied Globba pendula, a less common ginger plant found in 
Peninsula Malaysia. This plant has been used traditionally as a protective medicine 
after childbirth and for treating stomach complaints. No biological activity and 
chemical constituents have been reported on this species so far. 
 
Five of eight extracts including dichloromethane (rhizome and leaf), ethyl acetate 
(rhizome and leaf), and hexane (leaf) from the sequential extraction of Globba 
pendula were evaluated for cytotoxic activity. They exhibited cytotoxicity against 
MCF-7 cells (human breast cancer) with IC50 values ranging from 19.5 to 37.0 µg/ml. 
The statistical analysis of variance (ANOVA) showed that there were no significant 
(P<0.05) difference of the cytotoxic activity among the extracts. Phytochemical 
studies on the rhizomes and leaves of Globba pendula resulted in the isolation of two 
new compounds. They are 16-oxo-(8)17-12-labdadien-15,11-olide (92) and 
 i
benzofuran-2-carboxaldehyde (96), along with seven known compounds: 4-hydroxy-
3-methoxybenzoic acid (69), β-sitosterol (73), β-sitosteryl-β-D-glucopyranoside (90), 
7α-hydroxysitosterol (91), 3,14,19-trihydroxy-8(17),12-labdadien-16,15-olide (93), 
4-hydroxy-3-methoxybenzaldehyde (94), and 2(3H)-benzoxazolone (95). The 
structures of isolated compounds were established based on spectroscopic data and 
comparison with the literature. The compound 3,14,19-trihydroxy-8(17),12-
labdadien-16,15-olide (94) has demonstrated strong cytotoxic properties towards a 
panel of cancer cell lines (MCF-7, PC-3, and H-460) with the IC50 values of 7.9, 8.7, 
and 9.0 µM, respectively. 
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Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Master Sains 
 
KANDUNGAN KIMIA DAN AKTIVITI SITOTOKSIK HALIA ROYAN 
(GLOBBA PENDULA) 
 
Oleh 
MAULIDIANI 
December 2007 
 
Pengerusi: Profesor Md. Nordin Hj. Lajis, PhD 
Institut: Biosains 
 
Demi melanjutkan penyelidikan kami ke atas aspek kimia dan biologi daripada 
spesies Zingiberaceae, kami telah memilih Globba pendula, spesies yang tidak kerap  
ditemui di Malaysia. Menurut kajian etnomedik, tumbuhan Globba pendula 
digunakan sebagai ramuan selepas bersalin dan untuk merawat sakit perut. Setakat 
ini tiada laporan kajian kimia mahupun biologi ke atas spesies tersebut. 
 
Lima daripada lapan ekstrak tumbuhan Globba pendula yang didapati daripada 
pengekstrakan secara rendaman sejuk iaitu ekstrak diklorometana (akar dan daun), 
etil asetat (akar dan daun), dan heksana (daun) menunjukkan aktiviti sitotoksik 
terhadap sel kanser payudara (MCF-7) dengan IC50 19.5-37.0 µg/ml. Ujian statistic 
yang menggunakan analisis ANOVA menunjukkan tiada perbezaan yang signifikan 
(P<0.05) terhadap aktiviti sitotoksik di antara ekstrak-ekstrak. Kajian fitokimia akar 
dan daun Globba pendula berjaya memencilkan dua sebatian baru iaitu 16-okso-
 iii
(8)17-12-labdadiena-15,11-olida (92) dan benzofuran-2-karboksaldehid (96). Di 
samping itu turut diperolehi 4-hidroksi-3-metoksibenzoik asid (69), β-sitosterol (73), 
β-sitosteril-β-D-glukopiranosid (90), 7α-hidroksitosterol (91), 3,14,19-trihidroksi-
8(17),12-labdadiena-16,15-olida (93), 4-hidroksi-3-metoksibenzaldehid (94),  dan 
2(3H)-benzoxazolon (95). Struktur semua sebatian dikenal pasti berdasarkan kaedah 
spektroskopi dan perbandingan dengan literatur. 3,14,19-Trihidroksi-8(17),12-
labdadiena-16,15-olida (93) didapati sitotoksik ke atas panel sel-sel kanser, antaranya 
sel kanser payudara (MCF-7), sel kanser prostat (PC-3), dan sel kanser peparu (H-
460), dengan nilai  IC50 masing-masing 7.9, 8.7, dan 9.0 µM. 
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CHAPTER 1 
 
INTRODUCTION 
 
Plants have been used for thousands of years to treat man's illnesses and injuries. 
Despite the tremendous advances made by modern medical practices their 
contribution are still important until today (Soepadmo, 1998). The World Health 
Organization (WHO) estimated that as much as 80% of the world population 
relies on the use of various forms of traditional (herbal) medicine for its primary 
healthcare (Cragg et al., 1999; Narins, 2000). An impressive number of modern 
drugs have been isolated from natural sources based on their use in traditional 
medicines. Thus, the best way to find new applications of plant derived drugs 
would seem to be the combination of local knowledge and the modern research 
techniques available today. General method for obtaining active substances from 
plants is described in Scheme 1.1 below. 
 Medicinal Plant
 
 
 
 
 
 
2,1 
Toxicology Bioassay 
Total 
synthesis 
Structural 
modification 
Chemical characterization
Pure compounds
Fractions
Extracts
1. Fractionating process 
2. Purification 
 
Scheme 1.1: Method for obtaining active substances from plants (Rates, 2001) 
It is estimated that among estimated 250000-500000 identified plant species, only 
a small percentage of them have been investigated phytochemically and, even a 
smaller percentage, in terms of their pharmacological studies (Payne et al., 1991). 
This was further supported by Cordell (2003), who reported that less than 20% of 
all plant species have been evaluated chemically or biologically. Therefore, the 
potential uses of higher plants as a source of drugs still need to be explored. 
 
Malaysia is considered among the plant biodiversity hot spots of the world 
because of its tropical rainforests, which exhibits diversity and richness not only at 
the community level but also at the family and genus levels. It is estimated that 
about 10,000 species are present in Peninsular Malaysia with at least 1158 of them  
reported to have medicinal value. Apart from treating common illness such as 
headaches, coughs and colds, some species are also used for infectious diseases 
like malaria and cholera (Soepadmo, 1998). 
 
The ginger family, Zingiberaceae, is one of characteristic flora extensively found 
in Malaysia. For more than two decades there has been an increasing interest in 
the study of the plant family Zingiberaceae. Some of the popular species from the 
Zingiberaceae family have been studied for its chemical constituents, resulting in 
the isolation of numerous compounds, some of which may have potential 
properties as source of drugs. Below are some of the species from the 
Zingiberaceae family that have been studied in the Laboratory of Natural Products, 
Institute of Bioscience, Universiti Putra Malaysia (Table 1.1).  
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Table 1.1: Chemical and biological studies of some Zingiberaceae species 
 
Species Compound(s) isolated Biological activities
Hedychium thyrsiforme 
(Jasril et al., 2002) 
 
Flavonoids Antioxidant, 
anticancer  
Alpinia rafflesiana  
(Mohamad et al., 2004) 
 
 
Diarylheptanoid, flavonoids Antioxidant, 
antimicrobial, 
antiinflammatory 
Alpinia zerumbet 
(Mohamad, 2005) 
 
Diarylheptanoid, flavonoids Anticancer, 
antioxidant 
Etlingera elatior 
(Mohamad et al., 2005) 
 
Labdane diterpene, 
diarylheptanoids 
Anticancer, 
antioxidant 
Curcuma mangga    
(Abas et al., 2005) 
 
Curcumanggoside, labdane 
diterpenes, diarylheptanoids 
Anticancer, 
antioxidant 
Curcuma xanthorrhiza 
(Ruslay et al., 2007) 
 
Diarylheptanoids Antioxidant 
Zingiber zerumbet     
(Ruslay et al., 2007) 
Zerumbone, kaempferol 
glucosides 
Antioxidant 
 
 
The genus Globba is a member of the Zingiberaceae family. About one hundred 
species are recognized and most of them have their distribution within the 
northern monsoon area, from the eastern Himalayas through Burma and Thailand 
to Laos, Cambodia and Vietnam (Larsen, 1972). Unfortunately, very little 
information is known regarding their chemicals and biological properties. A 
species of the genus found throughout Peninsula Malaysia is Globba pendula. 
Ethnomedical reports mentioned Globba pendula as a herb used traditionally as 
protective medicine after childbirth (Burkill, 1966).  
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Cancer has become one of the important diseases to mankind. Over ten million 
new cases of cancer (all sites excluding non-melanoma skin), with over six 
million deaths, were estimated in the year 2000 (Parkin, 2001). Cancer is a group 
of many related diseases in which abnormal cells grow out of control and spread. 
The WHO has estimated that about 15 million new cases of cancer will develop in 
the year 2020, as compared to 10 million cases a year in the late 1990s. The 
reasons include increased smoking habit in the developing nations, unhealthy diets, 
and more people are living to old age when cancer risk is higher. The WHO also 
predicted that the prevalence of cancer cases will increase in the first 25 years of 
the twenty-first century in developing nations (Izenberg, 2000).  
 
Drug discovery from medicinal plants has played an important role in the 
treatment of cancer and, indeed, many new clinical applications of plant 
secondary metabolites and their derivatives over the last half century have been 
applied towards combating cancer (Newman et al., 2003; Butler, 2004). On the 
basis of the reasons mentioned, we are interested to search for new bioactive 
compounds from Globba pendula with cytotoxic activity against cancer cell-lines.  
 
 
The main objectives of this study are: 
1. To isolate and identify the chemical constituents in the leaves and 
rhizomes of Globba pendula. 
2. To determine the cytotoxic activity of the extract and isolated compounds 
from Globba pendula, against cancer cell-lines  
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